1Simko F. Left ventricular hypertrophy regression as a process with variable biological implication.Can J Cardiol,1996,12:507.
2Cooper G.Basic determinants of myocardial hypertrophy: a review of molecular mechanisms.Annu Rev Med,1997,48:13.
3Kacimi R,Long CS,Karliner JS.Chronic hypoxia modulates the interleukin-1beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes.Circulation.1997,16,96(6):1937-1943.
4Simpson PC.β-protein kinase C and hypertrophic signaling in human heart failure.Circulation,1999,99:334.
5Calls J,Cases A,Lario S,et al.Beta-adrenergic receptor density and function in left ventricular hypertrophy in young essential hypertensives.J Hum Hypertens,2000,14(1):17-21.
6Kardiol Z.Molecular basis of cardiac hypertrophy.Review,2000,89(1):1-6.
7Barry WH,Gilbert EM.How do beta-blockers improve ventricular function in patients with congestive heart failure?Circulation,2003,107(19):2395-2397.
8Takeo S,Elmoselhi AB,Goel R,et al.Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil.Mol Cell Biochem,2000,213(1-2):111-118.
9Reiken S,Wehrens XHT,Vest JA,et al.Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.Circulation,2003,107:2459-2466.
10Meyer M,Trost SU,Bluhm WF,et al.Impaired sarcoplasmic reticulum function leads to contractile dysfunction and cardiac hypertrophy.Am J Physiol Heart Circ Physiol,2001,280:2046-2052.
